Dapagliflozin 17228-6205
Product NDC
17228-6205- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- May 5, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dapagliflozin Propanediol | 5 mg/1 |
Packaging Options(1)
29000 TABLET, FILM COATED in 1 DRUM (17228-6205-0)